These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9773787)

  • 1. Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype.
    Ala Y; Morin D; Mouillac B; Sabatier N; Vargas R; Cotte N; Déchaux M; Antignac C; Arthus MF; Lonergan M; Turner MS; Balestre MN; Alonso G; Hibert M; Barberis C; Hendy GN; Bichet DG; Jard S
    J Am Soc Nephrol; 1998 Oct; 9(10):1861-72. PubMed ID: 9773787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional study of two V2 vasopressin mutant receptors related to NDI. P322S and P322H.
    Morin D; Ala Y; Sabatier N; Cotte N; Hendy G; Vargas R; Dechaux M; Antignac C; Hibert M; Bichet D; Barberis C
    Adv Exp Med Biol; 1998; 449():391-3. PubMed ID: 10026830
    [No Abstract]   [Full Text] [Related]  

  • 3. Mutations in the vasopressin V2 receptor and aquaporin-2 genes in 12 families with congenital nephrogenic diabetes insipidus.
    Vargas-Poussou R; Forestier L; Dautzenberg MD; Niaudet P; Déchaux M; Antignac C
    J Am Soc Nephrol; 1997 Dec; 8(12):1855-62. PubMed ID: 9402087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin receptor mutations causing nephrogenic diabetes insipidus.
    Bichet DG; Turner M; Morin D
    Proc Assoc Am Physicians; 1998; 110(5):387-94. PubMed ID: 9756088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical basis of partial nephrogenic diabetes insipidus phenotypes.
    Sadeghi H; Robertson GL; Bichet DG; Innamorati G; Birnbaumer M
    Mol Endocrinol; 1997 Nov; 11(12):1806-13. PubMed ID: 9369448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin type 2 receptor V88M mutation: molecular basis of partial and complete nephrogenic diabetes insipidus.
    Bockenhauer D; Carpentier E; Rochdi D; van't Hoff W; Breton B; Bernier V; Bouvier M; Bichet DG
    Nephron Physiol; 2010; 114(1):p1-10. PubMed ID: 19816050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of a novel mutant vasopressin receptor-dependent nephrogenic diabetes insipidus with bilateral non-obstructive hydronephrosis in a middle aged man: differentiation from aquaporin-dependent nephrogenic diabetes insipidus by response of factor VII and von Willebrand factor to 1-diamino-8-arginine vasopressin administration.
    Miyakoshi M; Kamoi K; Uchida S; Sasaki S
    Endocr J; 2003 Dec; 50(6):809-14. PubMed ID: 14709855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Misfolded vasopressin V2 receptors caused by extracellular point mutations entail congential nephrogenic diabetes insipidus.
    Postina R; Ufer E; Pfeiffer R; Knoers NV; Fahrenholz F
    Mol Cell Endocrinol; 2000 Jun; 164(1-2):31-9. PubMed ID: 11026555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrafamilial phenotype variability in nephrogenic diabetes insipidus.
    Kalenga K; Persu A; Goffin E; Lavenne-Pardonge E; van Cangh PJ; Bichet DG; Devuyst O
    Am J Kidney Dis; 2002 Apr; 39(4):737-43. PubMed ID: 11920339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model.
    Robben JH; Knoers NV; Deen PM
    Am J Physiol Renal Physiol; 2005 Aug; 289(2):F265-72. PubMed ID: 16006591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of a novel X-linked AVPR2 mutation causing partial nephrogenic diabetes insipidus: a case report and review of the literature.
    Neocleous V; Skordis N; Shammas C; Efstathiou E; Mastroyiannopoulos NP; Phylactou LA
    Metabolism; 2012 Jul; 61(7):922-30. PubMed ID: 22386940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of five novel vasopressin V2 receptor mutants causing nephrogenic diabetes insipidus reveals a role of tolvaptan for M272R-V2R mutation.
    Prosperi F; Suzumoto Y; Marzuillo P; Costanzo V; Jelen S; Iervolino A; Guarino S; La Manna A; Miraglia Del Giudice E; Perna AF; Zacchia M; Cordat E; Capasso G; Trepiccione F
    Sci Rep; 2020 Oct; 10(1):16383. PubMed ID: 33009446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification, characterization and rescue of a novel vasopressin-2 receptor mutation causing nephrogenic diabetes insipidus.
    Ranadive SA; Ersoy B; Favre H; Cheung CC; Rosenthal SM; Miller WL; Vaisse C
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):388-93. PubMed ID: 19170711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An extracellular congenital nephrogenic diabetes insipidus mutation of the vasopressin receptor reduces cell surface expression, affinity for ligand, and coupling to the Gs/adenylyl cyclase system.
    Birnbaumer M; Gilbert S; Rosenthal W
    Mol Endocrinol; 1994 Jul; 8(7):886-94. PubMed ID: 7984150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. V2R mutations and nephrogenic diabetes insipidus.
    Bichet DG
    Prog Mol Biol Transl Sci; 2009; 89():15-29. PubMed ID: 20374732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The property of a novel v2 receptor mutant in a patient with nephrogenic diabetes insipidus.
    Inaba S; Hatakeyama H; Taniguchi N; Miyamori I
    J Clin Endocrinol Metab; 2001 Jan; 86(1):381-5. PubMed ID: 11232028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. V2 vasopressin receptor (V2R) mutations in partial nephrogenic diabetes insipidus highlight protean agonism of V2R antagonists.
    Takahashi K; Makita N; Manaka K; Hisano M; Akioka Y; Miura K; Takubo N; Iida A; Ueda N; Hashimoto M; Fujita T; Igarashi T; Sekine T; Iiri T
    J Biol Chem; 2012 Jan; 287(3):2099-106. PubMed ID: 22144672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AVPR2 variants and V2 vasopressin receptor function in nephrogenic diabetes insipidus.
    Wildin RS; Cogdell DE; Valadez V
    Kidney Int; 1998 Dec; 54(6):1909-22. PubMed ID: 9853256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant).
    Bichet DG; Bockenhauer D
    Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):263-76. PubMed ID: 27156763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of three vasopressin receptor 2 variants: an apparent polymorphism (V266A) and two loss-of-function mutations (R181C and M311V).
    Armstrong SP; Seeber RM; Ayoub MA; Feldman BJ; Pfleger KD
    PLoS One; 2013; 8(6):e65885. PubMed ID: 23762448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.